Categories AlphaGraphs, Earnings, Technology

Cisco (CSCO) reports Q4 results: Here’s all you need to know

Cisco Systems Inc. (NASDAQ: CSCO) on Wednesday announced results for the fourth quarter of 2023, reporting higher revenues and earnings. The company also provided guidance for the first quarter of 2024.

Cisco Q4 2023 earnings infographic

The San Jose-headquartered network gear maker said that earnings, excluding special items, rose to $1.14 per share in the July quarter from $0.83 per share in the same period of 2022. Unadjusted net income was $4.0 billion or $0.97 per share, compared to last year’s profit of $2.8 billion or $0.68 per share.

At $15.2 billion, fourth-quarter revenues were up 16% year-over-year. The top line benefitted from strong contributions from the core Secure, Agile Networks division.

“We are seeing solid customer demand, gaining market share, and innovating in key areas like AI, security, and cloud. This momentum gives us confidence in our ability to capture the many opportunities ahead,” said Cisco’s CEO Chuck Robbins.

Prior Performance

  • Cisco Q2 2023 earnings infographic
  • Cisco-Q1-2023-Earnings-Infographic
  • Cisco Q4 2022 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Viewing Highlight